You need to be logged in to view this video
Learn from a seasoned investment banker of over 30 years the meaning of important concepts to enhance successful investing in biotechnology. Learn what such concepts as unmet medical need, standard of care, disease-modifying agent, breakthrough therapy, marketplace exclusivity, and more mean to allow you to enhance your knowledge of investing in biotechnology.
Daniel Montano
Zhittya Genesis Medicine, Inc.,
CEO
Dan Montano started at the Los Angeles Stock Exchange in 1968 as a floor broker. Over the next 30 years, he managed thousands of stockbrokers as CEO of several securities firms. As an investment banker, Mr. Montano handled the IPO's of over 100 companies from 1968 until 1998. During that time, he also assisted in starting almost 100 new companies to advance new technologies. In 1998, Mr. Montano left investment banking and dedicated himself to advance biotechnology breakthroughs. Presently, he is CEO of Zhittya Genesis Medicine Inc., a bio-pharmaceutical company developing drug treatments for heart disease, strokes, Parkinson's disease, Alzheimer's, and more.
Trending Now
Filter By Category
Filter By Keywords
Loading...